What Afortiori Development does

Afortiori Development Limited is a privately-held, founder-led Contract Research Organisation (CRO) headquartered in Nottingham, England, with additional registered offices in Galway, Ireland and the United States. The company provides full-service clinical trial design, planning and management for healthcare product developers, with current emphasis on medical devices (Classes I–III), drugs, diagnostics, and wearable technology products. Its offering is organised around three integrated phases — Clinical Strategy Planning (a half-day validation workshop), Clinical Trial Design, and Clinical Trial Management — supported by specialised modules for Medical Writing, Data Monitoring Committee services, Patient and Public Involvement, and Clinical Evaluation Report (CER) preparation. Delivery is professional services-based, project-priced and not publicly disclosed, with engagements sourced through direct enterprise sales, referrals, and a partner channel for CROs without UK/Ireland representation.

Operationally, Afortiori is built on a specialist team of medical writers, data managers, biostatisticians, regulatory specialists, medical monitors, clinical project managers, clinical research associates, and reimbursement specialists, anchored by co-founders Dr Nicola Wall and Elizabeth Ralph. The firm differentiates on a risk-based clinical trial management approach, ISO 9001:2015 certification, and a global trusted-partner network of clinicians, biostatisticians, regulatory and reimbursement experts. Customer evidence to date is limited and project-based, including a Japanese Class I medical device company entering the European market, a leading Irish university (multi-site Phase 2 SARS-CoV-2 study), and a small cardiovascular biotech (Phase I trials). The company is independently owned by its two founders with no disclosed external investment, parent company, or restructuring events.

Name

Afortiori Development

Legal name

Afortiori Development Limited

Website

https://aftdev.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

Afortiori Development is a founder-led UK-based full-service CRO providing clinical trial strategy, design, and management services for biopharmaceutical, medical device, diagnostics, and wearable technology innovators across the UK, Ireland, and the US.

Ownership category

akta.pro rank

Product category

Clinical Research Services (CRO)

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Other Scientific and Technical Consulting Services (541690)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Data Management, Biostatistics & Statistical Programming FSP (HLAGAOAB), Medical Writing & Clinical Documentation FSP (HLAGAOAC)

Keywords

• Clinical trial services
• Contract research organization
• Medical device clinical trials
• Clinical strategy planning
• Clinical trial management

Headquarters

HQ city

Nottingham

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Trial CRO Services: Full-service clinical research organisation providing end-to-end clinical trial services including strategy planning, trial design, and trial management. Revenue generated through professional services contracts for medical devices, drugs, and diagnostics development.
2. Clinical Strategy Planning Workshops: Half-day focused strategy workshops offering affordable, efficient approach to help clients develop clinical trial strategies. Workshop provides understanding of optimum clinical trial strategy, regulatory strategy insights, funding requirements, and access to global network of expertise.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Afortiori Development is a full-service Contract Research Organization (CRO) that designs, plans, and manages clinical trials and post-market clinical follow-up studies for medical devices, drugs, and diagnostics. The company offers a three-phase integrated service — Clinical Strategy Planning Workshops, Clinical Trial Design Services, and Clinical Trial Management Services — supplemented by Medical Writing, Data Monitoring Committee (DMC), Patient and Public Involvement (PPI), and Clinical Evaluation Report (CER) services. Its core offering is delivered as bespoke professional services engagements tailored to healthcare innovators across the UK, Ireland, the United States, and globally.

Product overview

Afortiori Development is a full-service Contract Research Organization (CRO) offering a comprehensive suite of clinical trial services. The core offering consists of three integrated phases: Clinical Strategy Planning Workshop (initial strategy and planning), Clinical Trial Design Services (protocol development and trial architecture), and Clinical Trial Management Services (execution and oversight). These are supplemented by specialized service modules including Medical Writing, DMC Services, PPI Services, and Clinical Evaluation Report (CER) Services. The integrated approach spans from initial concept through post-market clinical follow-up studies essential for regulatory approval and market uptake of healthcare products.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Strategy Planning Workshop A focused half-day strategy workshop led by founders Dr Nicola Wall and Elizabeth Ralph with clinical trial specialists, clinicians, biostatisticians, and regulatory/reimbursement experts. Delivers an understanding of the optimum clinical trial strategy, regulatory and commercial considerations, funding requirements, and access to a global network of expertise. Designed as an affordable, efficient entry point for healthcare innovators developing medical devices, drugs and diagnostics.
• Clinical Trial Design Services Comprehensive clinical trial design services including systematic literature review, key opinion leader sourcing, trial design incorporating pilot studies and biostatistics input, and reimbursement/market access considerations. Designed for medical device, drug and diagnostic innovators who need help designing an effective clinical trial.
• Clinical Trial Management Services Full-service clinical trial management including planning, site selection, regulatory/ethics coordination, database design, study monitoring, pharmacovigilance, data query resolution, and study close-out. Delivered using a risk-based approach to optimise recruitment, data collection and site performance, with proactive project management.
• Clinical Evaluation Report (CER) Services Post-clinical trial data analysis, management, and clinical evaluation report preparation for regulatory submissions. Supports medical device companies seeking regulatory approval and market uptake by translating clinical data into CERs aligned with applicable regulations.
• Medical Writing Services Professional medical writing services for clinical trial documentation, including protocols, informed consents, patient information leaflets, and study reports. Available as a standalone service for sponsors needing high-quality regulatory and clinical writing support.
• Data Monitoring Committee (DMC) Services Data Monitoring Committee support services providing independent safety oversight during clinical trials. Bookable as a standalone service for sponsors requiring independent safety review infrastructure.
• Patient and Public Involvement (PPI) Services Patient and public involvement services to identify recruitment issues and concerns, and to ensure trials are designed for participant retention. Bookable as a standalone service for sponsors and research consortia seeking patient-centred trial design.

Quantifiable outcome

• Cost-effective clinical trial design with best chance of success
• +1 more outcomes

Named customers3 records

Segments8 records

Ideal customer profiles6 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

One partnership is on record.

• Share CRFpreferred providerTechnology or IntegrationShare CRF is listed as the preferred provider for database design and implementation. The use of Share CRF ensures seamless database design and implementation, with effective data management support including training, query management, reports and data exports.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Parexel: Parexel is a major global CRO providing Phase I–IV clinical development, regulatory, and market access services to biopharma and medical device sponsors. It is a direct competitor for full-service trial work, with broader geographic reach and deeper therapeutic specialization than Afortiori.
• IQVIA: IQVIA is the largest global full-service CRO and clinical research services provider, offering trial design, management, real-world evidence, and technology platforms. It competes with Afortiori in the full-service clinical trial space, but at vastly greater scale and with proprietary technology.
• ICON plc: ICON is a top-tier global CRO offering full-service clinical research, laboratory, and consulting services across all therapeutic areas and phases. It overlaps directly with Afortiori's full-service clinical trial offering but serves much larger, late-stage programs globally.

Direct peers

• Veramed: Veramed is a UK-based CRO providing biostatistics, statistical programming, data management, and clinical trial services to pharma and medical device clients. It is comparable to Afortiori in geographic focus and mid-market CRO orientation, with overlapping biostatistics and trial management capabilities.
• Catapult Life Sciences: Catapult Life Sciences is a UK-based CRO providing clinical trial management, regulatory affairs, and pharmacovigilance services to pharma and medtech clients. It is a closely comparable peer in size, geography, and full-service orientation to mid-sized European sponsors.
• MAC Clinical Research: MAC Clinical Research is a UK-headquartered CRO operating early-phase clinical trials, including Phase I units, with biostatistics and data management capabilities. It is comparable to Afortiori in UK origin and clinical trial focus, though more concentrated in early-phase healthy volunteer studies.
• Richmond Pharmacology: Richmond Pharmacology is a UK-based CRO specializing in early-phase clinical trials, including first-in-human and clinical pharmacology studies. It is a relevant peer for Afortiori's early-phase drug work, given overlapping UK location and trial execution focus.
• Cromos Pharma: Cromos Pharma is a mid-sized full-service CRO with operations in Eastern Europe and the US, serving biopharma and medical device sponsors across multiple therapeutic areas. It competes for similar mid-market full-service work and offers comparable Phase II–IV capabilities.
• Clinipace Worldwide: Clinipace is a mid-sized full-service CRO focused on small to mid-sized biopharma and medical device sponsors, with therapeutic expertise across oncology, rare disease, and other areas. It mirrors Afortiori's target customer profile and full-service model but operates at greater scale in the US.

Emerging players

• Lindus Health: Lindus Health is an emerging tech-enabled CRO focused on running clinical trials for digital health, medical device, and consumer health sponsors. It overlaps with Afortiori's medical device and wearable technology segments but competes with a more software-driven, decentralized trial model.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/aftdevelopment
• LinkedInlinkedin.com/company/afortiori-development-ltd

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Afortiori Development